CRVS logo

Corvus Pharmaceuticals (CRVS) Current Liabilities

Annual Current Liabilities

$6.87 M
-$3.88 M-36.11%

December 31, 2023


Summary


Performance

CRVS Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCRVSbalance sheetmetrics:

Quarterly Current Liabilities

$46.41 M
+$33.07 M+248.00%

September 30, 2024


Summary


Performance

CRVS Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCRVSbalance sheetmetrics:

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

CRVS Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-36.1%+535.8%
3 y3 years-43.5%+331.6%
5 y5 years-2.3%+331.6%

CRVS Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-36.1%at lowat high+590.6%
5 y5-year-43.5%at lowat high+590.6%
alltimeall time-43.5%+156.9%at high+5016.4%

Corvus Pharmaceuticals Current Liabilities History

DateAnnualQuarterly
Sep 2024
-
$46.41 M(+248.0%)
Jun 2024
-
$13.34 M(+98.4%)
Mar 2024
-
$6.72 M(-2.2%)
Dec 2023
$6.87 M(-36.1%)
$6.87 M(-5.9%)
Sep 2023
-
$7.30 M(-7.1%)
Jun 2023
-
$7.86 M(-5.2%)
Mar 2023
-
$8.29 M(-22.9%)
Dec 2022
$10.75 M(+10.9%)
$10.75 M(-23.1%)
Sep 2022
-
$13.98 M(+37.6%)
Jun 2022
-
$10.16 M(+9.6%)
Mar 2022
-
$9.27 M(-4.4%)
Dec 2021
$9.69 M(-20.2%)
$9.69 M(-14.3%)
Sep 2021
-
$11.30 M(-8.5%)
Jun 2021
-
$12.36 M(-11.2%)
Mar 2021
-
$13.92 M(+14.5%)
Dec 2020
$12.15 M(+18.8%)
$12.15 M(+1.2%)
Sep 2020
-
$12.00 M(+3.9%)
Jun 2020
-
$11.55 M(-1.4%)
Mar 2020
-
$11.71 M(+14.5%)
DateAnnualQuarterly
Dec 2019
$10.22 M(+45.5%)
$10.22 M(+7.4%)
Sep 2019
-
$9.52 M(-11.1%)
Jun 2019
-
$10.70 M(+23.9%)
Mar 2019
-
$8.63 M(+22.9%)
Dec 2018
$7.03 M(-21.7%)
$7.03 M(-9.3%)
Sep 2018
-
$7.75 M(-20.8%)
Jun 2018
-
$9.78 M(-7.8%)
Mar 2018
-
$10.60 M(+18.2%)
Dec 2017
$8.97 M(+50.9%)
$8.97 M(-10.1%)
Sep 2017
-
$9.97 M(+4.8%)
Jun 2017
-
$9.52 M(+25.6%)
Mar 2017
-
$7.58 M(+27.5%)
Dec 2016
$5.94 M(+93.6%)
$5.94 M(+6.2%)
Sep 2016
-
$5.60 M(+55.1%)
Jun 2016
-
$3.61 M(+6.6%)
Mar 2016
-
$3.38 M(+10.2%)
Dec 2015
$3.07 M(+14.8%)
$3.07 M(+238.5%)
Sep 2015
-
$907.00 K
Dec 2014
$2.67 M
-

FAQ

  • What is Corvus Pharmaceuticals annual total current liabilities?
  • What is the all time high annual current liabilities for Corvus Pharmaceuticals?
  • What is Corvus Pharmaceuticals annual current liabilities year-on-year change?
  • What is Corvus Pharmaceuticals quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Corvus Pharmaceuticals?
  • What is Corvus Pharmaceuticals quarterly current liabilities year-on-year change?

What is Corvus Pharmaceuticals annual total current liabilities?

The current annual current liabilities of CRVS is $6.87 M

What is the all time high annual current liabilities for Corvus Pharmaceuticals?

Corvus Pharmaceuticals all-time high annual total current liabilities is $12.15 M

What is Corvus Pharmaceuticals annual current liabilities year-on-year change?

Over the past year, CRVS annual total current liabilities has changed by -$3.88 M (-36.11%)

What is Corvus Pharmaceuticals quarterly total current liabilities?

The current quarterly current liabilities of CRVS is $46.41 M

What is the all time high quarterly current liabilities for Corvus Pharmaceuticals?

Corvus Pharmaceuticals all-time high quarterly total current liabilities is $46.41 M

What is Corvus Pharmaceuticals quarterly current liabilities year-on-year change?

Over the past year, CRVS quarterly total current liabilities has changed by +$39.11 M (+535.79%)